Filing Flows

Filing Flows › Companies › United States Antimony › Cash flow

United States Antimony cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$18.9M in Q2 2026 · −$71.3M over twelve months

Operating cash flow−$8.7M
Capital spending−$10.2M
Free cash flow−$18.9M
Cash / net income-78.5×
Cash conversion cycle215 days

Analysis

In Q2 2026, United States Antimony generated −$8.7M of operating cash flow and spent $10.2M on capital projects, leaving free cash flow of −$18.9M. That is $11.7M less than in Q2 2025 (−$7.2M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$28.1M; the largest uses were capital spending ($43.2M), other investing ($37.9M), operating cash flow ($28.1M); besides operations, cash came from net borrowing (+) / repaid (−) ($148M), shares issued ($322K); the cash balance rose by $36.4M.

Operating cash flow was −$8.7M against net income of $110K — -78.5× profit, less cash than reported earnings, worth checking against working capital. The largest differences: stock-based pay +$2.9M, payables −$2.3M, prepaid and other assets −$1.6M.

Its cash conversion cycle was 215 days (receivables 29 + inventory 270 − payables 84).

Free cash flow

United States Antimony: free cash flow by quarterUnited States Antimony: free cash flow by quarter$339KQ3 2024$971KQ4 2024−$2.6MQ1 2025−$7.2MQ2 2025−$12.5MQ3 2025−$15.2MQ4 2025−$24.6MQ1 2026−$18.9MQ2 2026
Operating cash flow less capital spending.
United States Antimony: operating cash flow against capital spendingUnited States Antimony: operating cash flow against capital spendingOperating cash flowCapital spending$411K$72KQ3 2024$1.2M$208KQ4 2024−$1.7M$863KQ1 2025−$628K$6.5MQ2 2025−$3.9M$8.7MQ3 2025−$3.5M$11.7MQ4 2025−$12.1M$12.6MQ1 2026−$8.7M$10.2MQ2 2026
Latest (Q2 2026): Operating cash flow −$8.7M, Capital spending $10.2M.

Capital allocation, year by year

United States Antimony: where the cash came from (up) and went (down), by fiscal yearUnited States Antimony: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingBuybacksDividendsFY2021: Operating cash flow −$2.4MFY2021: Shares issued $23.3MFY2021: Capital spending −$648K$23.3MFY2021FY2022: Operating cash flow −$249KFY2022: Net borrowing −$65KFY2022: Capital spending −$1.7MFY2022: Buybacks −$203KFY2022FY2023: Operating cash flow −$4.8MFY2023: Net borrowing −$284KFY2023: Capital spending −$1.5MFY2023: Dividends −$788KFY2023FY2024: Operating cash flow $2.2MFY2024: Shares issued $4.4MFY2024: Asset sales $316KFY2024: Capital spending −$431K$6.9MFY2024FY2025: Operating cash flow −$9.7MFY2025: Net borrowing $104MFY2025: Shares issued $118KFY2025: Asset sales $13KFY2025: Capital spending −$27.8MFY2025: Buybacks −$449K$104MFY2025
Over these 5 years operating cash flow totalled −$14.9M; the largest uses were capital spending ($32.1M) and operating cash flow ($17.1M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$42.3M
Debt$335K
Net cash$41.9M
Due within a year$132K
Cash runway7 months

United States Antimony is burning cash: its operations consume cash, a free cash flow of −$71.3M a year at the current rate against $42.3M of cash and investments: a runway of about 7 months; $132K of debt also comes due within a year, which would need refinancing or new money before any new financing.

United States Antimony: debt maturities by year (FY2024)United States Antimony: debt maturities by year (FY2024)$132KYear 1$137KYear 2$58KYear 3
Principal due in each year as disclosed in the annual report, against $42.3M of cash and investments now.

Where the cash came from and went

United States Antimony: sources (+) and uses (−) of cash, Q2 2026United States Antimony: sources (+) and uses (−) of cash, Q2 2026Net borrowing (+) / repaid (−)$47.7MCash drawn (+) / kept (−)−$38.9MOther investing$11.7MCapital spending−$10.2MOperating cash flow−$8.7MBuybacks−$2.8MOther financing$931KShares issued$211K
United States Antimony: sources (+) and uses (−) of cash, TTM to Q2 2026United States Antimony: sources (+) and uses (−) of cash, TTM to Q2 2026Net borrowing (+) / repaid (−)$148MCapital spending−$43.2MOther investing−$37.9MCash drawn (+) / kept (−)−$36.4MOperating cash flow−$28.1MOther financing−$2.8MShares issued$322KAsset & business sales$15K

From profit to cash

United States Antimony: net income to operating cash flow, Q2 2026United States Antimony: net income to operating cash flow, Q2 2026Net income$110KDepreciation & amortization$515KStock-based pay$2.9MReceivables−$95KInventory$64KPayables−$2.3MAccrued liabilities−$1.3MPrepaid and other assets−$1.6MOperating cash flow−$8.7M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 20262927084215
Q1 202645274132187
Q4 202522934965
Q3 2025231056960
Q2 202520645330
Q1 202520514625
Q4 202416232910
Q3 202439313832

Every quarter

QuarterOperating cash flowCapital spendingBuybacksNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$8.7M−$10.2M−$2.8M$47.7M$211K−$38.9M−$18.9M
Q1 2026−$12.1M−$12.6M−$5.0M$1.3M$49K$27.3M−$24.6M
Q4 2025−$3.5M−$11.7M−$40K$65.7M$63K−$12.2M−$15.2M
Q3 2025−$3.9M−$8.7M—$33.3M—−$12.7M−$12.5M
Q2 2025−$628K−$6.5M——$4.1M$13.0M−$7.2M
Q1 2025−$1.7M−$863K——$3.2M−$575K−$2.6M
Q4 2024$1.2M−$208K—−$32K—−$5.2M$971K
Q3 2024$411K−$72K—−$32K—−$621K$339K

United States Antimony: income statement and cash flow

United States Antimony, Q2 2026: revenue $7.9M (-25% year over year), operating margin -88.1%. The chart follows the revenue to costs, profit and cash.

United States Antimony: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.